Phase Ib/2 Study of Selinexor (KPT330) in combination with Backbone treatment for R/R Multiple Myeloma

Clinical Trial Grant

Duke Scholars

Principal Investigator Cristina Gasparetto Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Karyopharm Therapeutics

Start Date

September 1, 2016

End Date

August 31, 2024

Administered By

Duke Cancer Institute

Awarded By

Karyopharm Therapeutics

Start Date

September 1, 2016

End Date

August 31, 2024